BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36467051)

  • 1. Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma
    Liu M; Hu T; Gou W; Chang H; Li Y; Li Y; Zuo D; Hou W; Jiao S
    Front Pharmacol; 2022; 13():993022. PubMed ID: 36467051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Icaritin increases radiosensitivity of nasopharyngeal carcinoma cells by regulating iron death].
    Hu T; Gou W; Ren Z; Liu G; Li Y; Zuo D; Hou W
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1665-1673. PubMed ID: 37933641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icaritin induces cellular senescence by accumulating the ROS production and regulation of the Jak2/Stat3/p21 pathway in imatinib-resistant, chronic myeloid leukemia cells.
    Zhu S; Xing C; Zhang G; Peng H; Wang Z
    Am J Transl Res; 2021; 13(8):8860-8872. PubMed ID: 34540000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence.
    Zuo B; Zuo L; Du XQ; Yuan S; Xuan C; Zhang YD; Chen ZW; Cao WF
    Front Pharmacol; 2022; 13():1033919. PubMed ID: 36386126
    [No Abstract]   [Full Text] [Related]  

  • 7. Network pharmacology and in vitro experiments reveal that Noscapine induces ROS-mediated apoptosis and cell cycle arrest via PI3K/Akt/FoxO3a signaling pathway in human bladder cancer cells.
    Su Y; Chen L; Yang J
    Curr Cancer Drug Targets; 2023 Jul; ():. PubMed ID: 37415366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells.
    Wang S; Wang Q; Wang H; Qin C; Cui X; Li L; Liu Y; Chang H
    Pharm Biol; 2019 Dec; 57(1):424-431. PubMed ID: 31407933
    [No Abstract]   [Full Text] [Related]  

  • 10. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effect of icaritin on human lung cancer cells through inducing S phase cell cycle arrest and apoptosis.
    Zheng Q; Liu WW; Li B; Chen HJ; Zhu WS; Yang GX; Chen MJ; He GY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Aug; 34(4):497-503. PubMed ID: 25135717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma
    Liu M; Hu T; Gou W; Chang H; Li Y; Li Y; Zuo D; Hou W; Jiao S
    Front Pharmacol; 2023; 14():1140018. PubMed ID: 36798079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology and Experimental Validation to Elucidate the Pharmacological Mechanisms of Luteolin Against Chondrocyte Senescence.
    Long L; Tang X; Wang Y; Gu J; Xiong J; Luo H; Lv H; Zhou F; Cao K; Lin S
    Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38299289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
    Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology.
    Zhang Z; Fang J; Sun D; Zheng Y; Liu X; Li H; Hu Y; Liu Y; Zhang M; Liu W; Zhang X; Liu X
    Evid Based Complement Alternat Med; 2022; 2022():6987677. PubMed ID: 36561604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1.
    Wang Y; Wang G; Liu Y; Yang F; Zhang H; Kong Y
    Phytomedicine; 2023 Nov; 120():155062. PubMed ID: 37683586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation.
    Jin YB; Liang XC; Cai JH; Wang K; Wang CY; Wang WH; Chen XL; Bao S
    Front Oncol; 2023; 13():1205604. PubMed ID: 37538114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
    Yuan S; Xu Y; Yi T; Wang H
    J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.
    Zhou Z; Yin Y; Chang Q; Sun G; Lin J; Dai Y
    Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 27878894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.
    Huang X; Zhu D; Lou Y
    Eur J Pharmacol; 2007 Jun; 564(1-3):26-36. PubMed ID: 17382317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.